Unlock stock picks and a broker-level newsfeed that powers Wall Street.

ASX - Delayed Quote AUD

Opthea Limited (OPT.AX)

Compare
0.6000
0.0000
(0.00%)
At close: March 14 at 4:10:39 PM GMT+11
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
124.6660
124.6660
108.4060
90.6830
68.6130
Cost of Revenue
--
--
166.8260
160.5010
428.9010
Gross Profit
--
--
-58.4200
-69.8180
-360.2880
Operating Expense
191,967.3990
191,967.3990
149,967.3740
96,468.1450
39,281.6600
Operating Income
-191,842.7330
-191,842.7330
-150,025.7940
-96,537.9630
-39,641.9480
Net Non Operating Interest Income Expense
-26,868.3160
-26,868.3160
-10,234.6640
235.4680
372.0010
Other Income Expense
-10,943.2520
-10,943.2520
11,813.0230
-2,814.1620
-11,013.3950
Pretax Income
-229,654.3010
-229,654.3010
-148,447.4350
-99,116.6570
-50,283.3420
Tax Provision
-9,412.1960
-9,412.1960
-5,926.3500
-6,299.2860
-4,938.8460
Net Income Common Stockholders
-220,242.1050
-220,242.1050
-142,521.0850
-92,817.3710
-45,344.4960
Diluted NI Available to Com Stockholders
-220,242.1050
-220,242.1050
-142,521.0850
-92,817.3710
-45,344.4960
Basic EPS
-0.28
--
-0.28
-0.23
-0.12
Diluted EPS
-0.28
--
-0.28
-0.23
-0.12
Basic Average Shares
578,016.6310
--
509,803.5460
404,906.2130
369,055.5350
Diluted Average Shares
578,016.6310
--
509,803.5460
404,906.2130
369,055.5350
Total Operating Income as Reported
-191,842.7330
-191,842.7330
--
--
--
Rent Expense Supplemental
--
--
--
21.3070
18.4450
Total Expenses
191,967.3990
191,967.3990
150,134.2000
96,628.6460
39,710.5610
Net Income from Continuing & Discontinued Operation
-220,242.1050
-220,242.1050
-142,521.0850
-92,817.3710
-45,344.4960
Normalized Income
-209,375.9419
-209,375.9419
-142,051.4754
-90,182.0610
-35,412.8402
Interest Income
3,394.7260
3,394.7260
3,227.4960
235.4680
372.0010
Interest Expense
30,263.0420
30,263.0420
13,462.1600
--
--
Net Interest Income
-26,868.3160
-26,868.3160
-10,234.6640
235.4680
372.0010
EBIT
-199,391.2590
-199,391.2590
-134,985.2750
-99,116.6570
-50,283.3420
EBITDA
-199,288.2340
-199,288.2340
-134,884.0480
-99,038.2750
-50,176.6740
Reconciled Cost of Revenue
--
--
166.8250
160.5010
428.9010
Reconciled Depreciation
103.0250
103.0250
101.2270
78.3820
106.6680
Net Income from Continuing Operation Net Minority Interest
-220,242.1050
-220,242.1050
-142,521.0850
-92,817.3710
-45,344.4960
Total Unusual Items Excluding Goodwill
-11,330.5360
-11,330.5360
-489.1370
-2,814.1620
-11,013.3950
Total Unusual Items
-11,330.5360
-11,330.5360
-489.1370
-2,814.1620
-11,013.3950
Normalized EBITDA
-187,957.6980
-187,957.6980
-134,394.9110
-96,224.1130
-39,163.2790
Tax Rate for Calcs
0
0
0
0.0001
0.0001
Tax Effect of Unusual Items
-464.3729
-464.3729
-19.5274
-178.8520
-1,081.7392
6/30/2021 - 1/28/1988

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CYP.AX Cynata Therapeutics Limited
0.1900
+5.56%
 
UR9.MU Clinuvel Pharmaceuticals Limited
5.50
-4.84%
 
PHMMF Pharma Mar, S.A.
88.18
0.00%
 
ZLD.AX Zelira Therapeutics Limited
0.4700
-6.00%
 
SPL.AX Starpharma Holdings Limited
0.0960
+5.49%
 
RAD.AX Radiopharm Theranostics Limited
0.0210
+5.00%
 
4593.T Healios K.K.
224.00
+0.90%
 
TLX.AX Telix Pharmaceuticals Limited
24.42
-1.57%
 
CU6.AX Clarity Pharmaceuticals Ltd
1.4600
-5.19%
 
IMM.AX Immutep Limited
0.2350
-6.00%